GBS Inc. to Present First Quarter 2022 Financial Results and Recent Corporate Update on November 11

NEXT STORY
Ziopharm Oncology to Report Third Quarter Financial Results on November 8, 2021
PREV STORY
Context Therapeutics® Strengthens Leadership Team with Appointments of Chief Financial Officer and Chief Legal Officer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Foghorn Therapeutics Provides Corporate Update

author_avatar
NASDAQ Market News

Immunicum AB (publ) Gives Information on Trading Halt and Ongoing Negotiations for a Potential Collaboration

Press Release 1 October 2018 Immunicum AB (publ) Gives Information on Trading Halt and ...

author_avatar
NASDAQ Market News

Aerpio Pharmaceuticals, Inc. Announces a Second Clinical Trial with Funding from MTEC to Evaluate Razuprotafib for the Prevention and Treatment of ARDS in Patients with Moderate to Severe COVID-19

author_avatar
NASDAQ Market News